Stocks
Jaguar Health, Inc.JAGX
NASDAQHealthcareBiotechnology$2.15
Price as of · delayed, not real-time
A commercial-stage biopharmaceutical company focused on developing plant-based prescription medicines for gastrointestinal conditions, with its lead product Mytesi approved for HIV-associated diarrhea. Investors track it for its rare disease pipeline and ongoing efforts to expand into broader indications.
52W Range: $2.15-$1118.25
Congressional Interest in Jaguar Health, Inc. (JAGX)
No congressional trades have been disclosed for Jaguar Health, Inc. (JAGX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading JAGX?
No congressional trades found for this stock.